This website uses cookies to enhance the browsing experience. By continuing you give us permission to deploy cookies as per our privacy and cookies policy.

About Melinta

Melinta Therapeutics is a biopharmaceutical company founded by Sterling Professors at Yale University

Our mission is to apply Nobel Prize–winning science to develop new therapeutics in the global fight against drug-resistant pathogens.

We are the proud developers of BAXDELA, an important therapeutic milestone in the treatment of serious skin infections in adult patients.

Visit us at Melinta.com to learn more.

Melinta Therapeutics

Melinta Therapeutics, LLC - Unparalleled in passion & purpose

Medical Information
For medical inquiries or to report an adverse event, other safety-related information, or product complaints for a company product, please contact Medical Information. Phone: 1-844-MED-MLNT (1-844-633-6568)
medinfo@melinta.com
www.melintamedicalinformation.com

©2021 All rights reserved. PP-BAX-US-0399 Terms of Use

BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.